This grant, offered by the National Institute of Allergy and Infectious Diseases (NIAID) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), encourages applications for the Mucosal Environment and HIV Prevention (MEHP) program. It aims to support innovative proof-of-concept and feasibility research in non-vaccine biomedical prevention (nBP), specifically for safer and more effective microbicides, Pre-Exposure Prophylaxis (PrEP), and Multipurpose Prevention Technologies (MPT). The focus is on understanding how prevention candidates interact with the micro- and macro-environments of the genital (male and female) and gastrointestinal mucosa. Key underserved areas addressed include the microbiome’s role in HIV transmission and candidate safety, tissue responses to prevention agents, and the effect of genital secretions and hormones on susceptibility to HIV infection.
Opportunity ID: 225473
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-AI-13-012 |
| Funding Opportunity Title: | Mucosal Environment and HIV Prevention (MEHP) (R01) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy, Immunology and Transplantation Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Mar 07, 2013 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Jul 25, 2013 |
| Current Closing Date for Applications: | Jul 25, 2013 |
| Archive Date: | Aug 25, 2013 |
| Estimated Total Program Funding: | – |
| Award Ceiling: | $400,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | County governments State governments Native American tribal organizations (other than Federally recognized tribal governments) City or township governments Special district governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Public and State controlled institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts Native American tribal governments (Federally recognized) Private institutions of higher education Small businesses Public housing authorities/Indian housing authorities |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | The National Institute of Allergy and Infectious Diseases (NIAID) and the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD), National Institutes of Health, encourages grant applications from institutions/organizations that address the goals and objectives of this funding opportunity announcement (FOA). The Mucosal Environment and HIV Prevention (MEHP) FOA is intended to support innovative proof-of-concept/feasibility non-vaccine biomedical prevention (nBP) research needed to support and advance the development of safer and more effective microbicides, Pre-Exposure Prophylaxis (PrEP), and Multipurpose Prevention Technologies (MPT). It will achieve this by supporting a better understanding of prevention candidates and strategy interaction with the micro- and macro-environments of the genital (male and female) and gastrointestinal (GI) mucosa. The MEHP FOA addresses the following 3 underserved emerging areas of Program interest: role of the microbiome in transmission/acquisition of HIV and candidate safety and efficacy, tissue responses to prevention agents, and the effect of genital secretions and hormones on susceptibility to HIV infection: |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-13-012.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| ADOBE-FORMS-B2 | Adobe-Forms-B2 | PKG00169050 | Jun 25, 2013 | Jul 25, 2013 | View |
Package 1
Mandatory forms
225473 RR_SF424_1_2-1.2.pdf
225473 PerformanceSite_1_4-1.4.pdf
225473 RR_OtherProjectInfo_1_3-1.3.pdf
225473 RR_KeyPersonExpanded_1_2-1.2.pdf
225473 PHS398_CoverPageSupplement_1_4-1.4.pdf
225473 PHS398_ResearchPlan_1_3-1.3.pdf
225473 PHS398_Checklist_1_3-1.3.pdf
Optional forms
225473 RR_SubawardBudget30-1.2.pdf
225473 PHS398_ModularBudget_1_2-1.2.pdf
225473 RR_Budget-1.1.pdf
225473 PHS_CoverLetter_1_2-1.2.pdf